Your session is about to expire
← Back to Search
Dietary Supplement
Graded Protein plus Resistance Training for Sarcopenia (GPI Trial)
N/A
Waitlist Available
Led By Gary D Miller, Ph.D.
Research Sponsored by Wake Forest University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 5, week 10
Awards & highlights
GPI Trial Summary
This study is evaluating whether a graded protein intake may help improve muscle size and function.
GPI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 5, week 10
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 5, week 10
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Whole body fat mass (kg) from baseline to 10 weeks
Change in Whole body lean soft tissue mass (kg) from baseline to 10 weeks
Change in regional (specifically the lower extremity) fat mass (kg) from baseline to 10 weeks
+1 moreSecondary outcome measures
Change in Muscle Tissue Thickness from baseline to 10 weeks
Change in Muscular Function (3 repetition maximum) from baseline to 5 weeks to 10 weeks
Muscle Proteins
+1 moreGPI Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Graded Protein plus Resistance TrainingExperimental Treatment1 Intervention
This group will participate in a progressive resistance training program and will be instructed to consume a diet with a gradation of protein over the 12 week study duration.
Group II: RDA Protein plus Resistance TrainingActive Control1 Intervention
This group will participate in a progressive resistance training program and will be instructed to consume a diet with the recommended daily allowance of protein over the 12 week study duration.
Find a Location
Who is running the clinical trial?
Wake Forest UniversityLead Sponsor
190 Previous Clinical Trials
164,580 Total Patients Enrolled
1 Trials studying Sarcopenia
24 Patients Enrolled for Sarcopenia
Gary D Miller, Ph.D.Principal InvestigatorWake Forest University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger